Physician profile
Constantine Andreas Serkes
NPI 1003920927
$976.17
in general payments reported to CMS, 2019-2025
14 companies · $93.04 in 2025
The $93.04 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $83.83 · 2022: $133 · 2023: $314 · 2024: $154 · 2025: $93.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $202.84 | 2022-2025 | |
| Corium, LLC | $129.61 | 2022-2023 | Azstarys |
| Sanofi Pasteur INC. | $125.50 | 2019-2025 | |
| Genentech USA, INC. | $104.81 | 2019-2022 | |
| Kaleo, INC. | $95.00 | 2019-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $76.84 | 2023-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Glaxosmithkline, LLC. | $51.93 | 2019-2023 | Bexsero |
| Cranial Technologies, INC | $50.17 | 2023 | Doc Band |
| Hologic Sales and Service, LLC | $32.23 | 2019-2023 | Affirm Prone Biopsy System |
| Tris Pharma INC | $30.84 | 2019 | |
| Seqirus USA INC | $27.78 | 2024 | Flucelvax |
| Shire North American Group INC | $21.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.05 | 2024 | |
| Neos Therapeutics, Lp | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Serkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.